As Chief Executive Officer (CEO) of CONNECT, Greg McKee brings nearly 30 years of experience in the healthcare, investment management and investment banking industries to CONNECT. He was co–Founder of Global Bio Link, a global Specialty Pharma company focused on the commercialization of novel and niche compounds in markets outside the United States. Prior to Global Bio Link, Greg was Chairman and CEO of Akela Pharma Inc. and its predecessor company, Nventa Biopharmaceuticals. Previously, Greg held roles as Head Corporate Development, Valentis, Inc., and Senior Management roles with Genzyme Corporation in the US and Asia. Greg lived and worked in Japan and in Singapore for nine years and speaks fluent Japanese. An active member of Young Presidents Organization (YPO)/World Presidents Organization (WPO), Greg earned a B.A., Economics from the University of Washington, a M.B.A from the Wharton School, and a M.A., International Studies from The Joseph H. Lauder Institute of the University of Pennsylvania.